The probability of developing ocular EIMs was comparable across treatment classes among patients with HLA-B27-associated diseases.

Tetrachloroethylene (PCE) exposure was linked to a tripled risk for significant liver fibrosis, with a dose-dependent effect.

Moderate-to-vigorous physical activity guideline adherence was associated with a 22% and 17% lower CHD risk in women and men, respectively.

There was a significant association between early age of natural menopause vs late age and metabolic syndrome.

Type 2 diabetes prevalence among children aged 5 years or less is associated with social and environmental factors.

Ustekinumab and vedolizumab have comparable safety and efficacy in older and younger adults with IBD, indicating that age should not be a deterrent for treatment.

Individuals with MetALD vs MASLD have significantly higher risks for liver-related events, liver cancer, and extrahepatic cancers.

The presence of metabolic dysfunction-associated steatotic liver disease may be a predictor of disease trajectory in patients with MACE.

MACE risk was associated with waist circumference reduction but not weight loss among those receiving semaglutide.

Sugar rationing during the first 1000 days of life was associated with a reduction in the risk for cardiovascular outcomes in adulthood.

Patient and graft survival were similar for transplants from medical assistance in dying donation after circulatory death vs conventional grafts.

Virtual weight management was associated with significantly weight loss at 6, 12, and 18 months among patients with obesity and with or without T2D.